In the inaugural lecture of the 2024 Centennial Front Row series, President and CEO Peter Schultz will illuminate how Scripps Research is building on its storied past—a remarkable century of discovery and innovation—to establish a new paradigm for the future of science and medicine. Under Schultz’s leadership, Scripps Research is expanding its global impact by empowering exceptional scientists to pursue groundbreaking ideas and seamlessly blending curiosity-fueled science with impact-driven drug discovery. Schultz shared how this unique approach is already giving rise to a new generation of first-in-class medicines against cancers, heart disease, deadly pathogens, neurological disorders, and many other health threats.

Presented: January 10, 2024

Presentation top takeaways